| Id: | acc4850 |
| Group: | 1sens |
| Protein: | p53 |
| Gene Symbol: | TP53 |
| Protein Id: | P04637 |
| Protein Name: | P53_HUMAN |
| PTM: | phosphorylation |
| Site: | Ser46 |
| Site Sequence: | SQAMDDLMLSPDDIEQWFTED |
| Disease Category: | Cardiovascular and circulatory system diseases |
| Disease: | Cerebral Ischemia-Reperfusion Injury |
| Disease Subtype: | SH-SY5Y cells subjected to oxygen-glucose deprivat |
| Disease Cellline: | SH-SY5Y |
| Disease Info: | |
| Drug: | DhHP-3 |
| Drug Info: | "DhHP-3 is a drug, but detailed information about its properties and functions is not provided." |
| Effect: | modulate |
| Effect Info: | "The drug inhibits the phosphorylation level of p53 in the CIRI cell model, suppresses cell apoptosis, and alleviates symptoms." |
| Note: | |
| Score: | 4.0 |
| Pubmed(PMID): | 36442518 |
| Sentence Index: | 36442518_5 |
| Sentence: | "DhHP-3 could reduce ROS, down-regulate apoptotic proteins, suppress p53 phosphorylation, attenuate the DNA damage response (DDR), and inhibit apoptosis in SH-SY5Y cells subjected to oxygen-glucose deprivation/re-oxygenation (OGD/R) and in the brain of Sprague Dawley rats subjected to transient middle cerebral artery occlusion." |
Sequence & Structure:
MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD
Select PDB:
| Target | Drug name | MOA | Phase | Status | Disease | Source |
|---|---|---|---|---|---|---|
| TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 3 | Completed | myelodysplastic syndrome | ClinicalTrials |
| TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 3 | Terminated | acute myeloid leukemia | ClinicalTrials |
| TP53 | CENERSEN SODIUM | p53 mRNA antisense inhibitor | 2 | Terminated | chronic lymphocytic leukemia | ClinicalTrials |
| TP53 | CENERSEN | p53 mRNA antisense inhibitor | 2 | Completed | acute myeloid leukemia | ClinicalTrials |
| TP53 | CENERSEN | p53 mRNA antisense inhibitor | 2 | Withdrawn | acute myeloid leukemia | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | essential thrombocythemia | ClinicalTrials |
| TP53 | SIREMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | neoplasm | ClinicalTrials |
| TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | neoplasm | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Terminated | small cell lung carcinoma | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Active, not recruiting | polycythemia vera | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | polycythemia vera | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | primary myelofibrosis | ClinicalTrials |
| TP53 | IDASANUTLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Terminated | polycythemia vera | ClinicalTrials |
| TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Unknown status | non-small cell lung carcinoma | ClinicalTrials |
| TP53 | APG115 | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | lymphoid leukemia | ClinicalTrials |
| TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Terminated | head and neck malignant neoplasia | ClinicalTrials |
| TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Unknown status | head and neck malignant neoplasia | ClinicalTrials ClinicalTrials |
| TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 2 | Withdrawn | Mantle cell lymphoma | ClinicalTrials |
| TP53 | TEPRASIRAN | p53 mRNA RNAi inhibitor | 2 | Completed | Acute kidney injury | ClinicalTrials |
| TP53 | EPRENETAPOPT | Cellular tumor antigen p53 stabiliser | 2 | Completed | ovarian cancer | ClinicalTrials |
| TP53 | CONTUSUGENE LADENOVEC | Cellular tumor antigen p53 exogenous gene | 2 | Completed | breast cancer | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 2 | Recruiting | endometrial cancer | ClinicalTrials |
| TP53 | CENERSEN | p53 mRNA antisense inhibitor | 1 | Terminated | myelodysplastic syndrome | ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 1 | Active, not recruiting | acute myeloid leukemia | ClinicalTrials ClinicalTrials |
| TP53 | NAVTEMADLIN | Tumour suppressor p53/oncoprotein Mdm2 inhibitor | 1 | Completed | acute myeloid leukemia | ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo intensity data of this site,
show all other sites!
| TP53-Ser314 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53-Ser315 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -1.105 |
| HGSC | 0.842 |
| ccRCC | 0.263 |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53-Thr150 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser101 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.422 |
| HGSC | -1.142 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.72 |
| TP53BP1-Ser1024 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | 0.707 |
| GBM | |
| HNSC | |
| LUAD | -0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1030 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -1.646 |
| HGSC | |
| ccRCC | 0.325 |
| GBM | 1.443 |
| HNSC | -0.173 |
| LUAD | 0.213 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.162 |
| TP53BP1-Ser1033 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.211 |
| COAD | -0.937 |
| HGSC | 2.312 |
| ccRCC | -0.583 |
| GBM | -0.187 |
| HNSC | -0.362 |
| LUAD | -0.923 |
| LUSC | -0.762 |
| non_ccRCC | 0.539 |
| PDAC | -0.285 |
| UCEC | -0.023 |
| TP53BP1-Ser1039 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | 0.707 |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.707 |
| TP53BP1-Ser1072 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 1.378 |
| ccRCC | 0.381 |
| GBM | 0.572 |
| HNSC | -1.199 |
| LUAD | -1.107 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.682 |
| TP53BP1-Ser1073 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.669 |
| COAD | -1.359 |
| HGSC | 1.711 |
| ccRCC | 0.013 |
| GBM | -1.1 |
| HNSC | -0.352 |
| LUAD | -0.325 |
| LUSC | -0.93 |
| non_ccRCC | 1.416 |
| PDAC | 0.594 |
| UCEC | -0.338 |
| TP53BP1-Ser108 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -1.494 |
| ccRCC | 0.385 |
| GBM | |
| HNSC | 0.592 |
| LUAD | 0.518 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1091 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.162 |
| COAD | |
| HGSC | |
| ccRCC | 0.068 |
| GBM | |
| HNSC | -0.502 |
| LUAD | -1.047 |
| LUSC | |
| non_ccRCC | 1.887 |
| PDAC | |
| UCEC | -0.245 |
| TP53BP1-Ser1099 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.026 |
| COAD | -0.791 |
| HGSC | 2.796 |
| ccRCC | -0.009 |
| GBM | -0.536 |
| HNSC | -0.528 |
| LUAD | -0.656 |
| LUSC | -0.569 |
| non_ccRCC | 0.469 |
| PDAC | -0.136 |
| UCEC | -0.016 |
| TP53BP1-Ser110 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.172 |
| COAD | |
| HGSC | -1.547 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -0.219 |
| LUSC | 0.235 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.359 |
| TP53BP1-Ser1106 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.4 |
| COAD | -1.116 |
| HGSC | -0.312 |
| ccRCC | 0.547 |
| GBM | -0.568 |
| HNSC | -0.441 |
| LUAD | -0.968 |
| LUSC | -0.471 |
| non_ccRCC | 2.364 |
| PDAC | 0.704 |
| UCEC | 0.661 |
| TP53BP1-Ser1109 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.039 |
| HGSC | -2.593 |
| ccRCC | 0.274 |
| GBM | 0.059 |
| HNSC | 0.319 |
| LUAD | |
| LUSC | 0.217 |
| non_ccRCC | 0.798 |
| PDAC | 0.535 |
| UCEC | 0.352 |
| TP53BP1-Ser1118 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.141 |
| HGSC | -1.543 |
| ccRCC | -1.102 |
| GBM | 0.247 |
| HNSC | 1.264 |
| LUAD | -0.614 |
| LUSC | 0.464 |
| non_ccRCC | -0.502 |
| PDAC | 1.68 |
| UCEC | 0.245 |
| TP53BP1-Ser1119 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.086 |
| HGSC | -2.266 |
| ccRCC | 0.103 |
| GBM | 0.966 |
| HNSC | 0.693 |
| LUAD | 0.411 |
| LUSC | |
| non_ccRCC | |
| PDAC | -0.265 |
| UCEC | 0.442 |
| TP53BP1-Ser1221 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1224 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser124 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.494 |
| HGSC | -1.151 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 0.657 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1293 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -1.016 |
| HGSC | 1.342 |
| ccRCC | |
| GBM | 0.076 |
| HNSC | -0.402 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1295 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.707 |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1300 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.707 |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1301 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.707 |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser132 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.744 |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -1.235 |
| LUSC | 0.878 |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.387 |
| TP53BP1-Ser1322 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1325 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1327 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1347 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.707 |
| TP53BP1-Ser1367 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.307 |
| HGSC | 1.914 |
| ccRCC | -0.145 |
| GBM | |
| HNSC | -0.147 |
| LUAD | -1.067 |
| LUSC | |
| non_ccRCC | |
| PDAC | -0.247 |
| UCEC | |
| TP53BP1-Ser1431 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.246 |
| COAD | 0.043 |
| HGSC | -2.497 |
| ccRCC | 0.213 |
| GBM | 0.159 |
| HNSC | -0.014 |
| LUAD | -0.134 |
| LUSC | -0.797 |
| non_ccRCC | 1.417 |
| PDAC | 0.55 |
| UCEC | 0.816 |
| TP53BP1-Ser1435 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.113 |
| COAD | -0.034 |
| HGSC | -2.759 |
| ccRCC | 0.293 |
| GBM | 0.398 |
| HNSC | -0.001 |
| LUAD | -0.361 |
| LUSC | 0.187 |
| non_ccRCC | 0.999 |
| PDAC | 0.705 |
| UCEC | 0.686 |
| TP53BP1-Ser1467 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.052 |
| HGSC | -1.961 |
| ccRCC | 0.335 |
| GBM | |
| HNSC | 0.235 |
| LUAD | 0.458 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.88 |
| TP53BP1-Ser1479 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.04 |
| COAD | |
| HGSC | |
| ccRCC | -0.431 |
| GBM | |
| HNSC | -0.965 |
| LUAD | -0.754 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 1.11 |
| TP53BP1-Ser1485 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -1.145 |
| ccRCC | |
| GBM | |
| HNSC | 0.704 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.441 |
| TP53BP1-Ser1486 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.176 |
| HGSC | -1.675 |
| ccRCC | |
| GBM | 0.676 |
| HNSC | 0.499 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.676 |
| TP53BP1-Ser1553 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.399 |
| COAD | -0.09 |
| HGSC | -1.597 |
| ccRCC | -0.186 |
| GBM | 2.062 |
| HNSC | -0.731 |
| LUAD | 0.544 |
| LUSC | |
| non_ccRCC | -0.011 |
| PDAC | |
| UCEC | 0.406 |
| TP53BP1-Ser1570 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.707 |
| TP53BP1-Ser1623 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.109 |
| COAD | 0.706 |
| HGSC | -0.313 |
| ccRCC | 0.633 |
| GBM | -0.649 |
| HNSC | -0.116 |
| LUAD | -0.594 |
| LUSC | -2.106 |
| non_ccRCC | |
| PDAC | 1.333 |
| UCEC | 0.996 |
| TP53BP1-Ser1636 | |
|---|---|
| Cancer | Intensity |
| BRCA | 2.069 |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | -0.803 |
| HNSC | 0.499 |
| LUAD | -0.343 |
| LUSC | -0.484 |
| non_ccRCC | |
| PDAC | -0.596 |
| UCEC | -0.341 |
| TP53BP1-Ser1639 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.707 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.707 |
| TP53BP1-Ser1640 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.48 |
| HGSC | -2.197 |
| ccRCC | |
| GBM | 0.518 |
| HNSC | -0.103 |
| LUAD | |
| LUSC | 0.197 |
| non_ccRCC | 0.631 |
| PDAC | 0.473 |
| UCEC | |
| TP53BP1-Ser1647 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.281 |
| HGSC | 1.11 |
| ccRCC | -0.829 |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1648 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 1.462 |
| ccRCC | -0.179 |
| GBM | -0.704 |
| HNSC | -0.579 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1649 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.509 |
| HGSC | 1.152 |
| ccRCC | |
| GBM | -0.643 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1650 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.045 |
| HGSC | 1.661 |
| ccRCC | |
| GBM | -0.557 |
| HNSC | -0.1 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.959 |
| TP53BP1-Ser1670 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.256 |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 1.05 |
| HNSC | 0.489 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.283 |
| TP53BP1-Ser1678 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.443 |
| COAD | |
| HGSC | |
| ccRCC | 0.603 |
| GBM | |
| HNSC | 0.93 |
| LUAD | -1.54 |
| LUSC | 0.45 |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1683 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.772 |
| COAD | 0.322 |
| HGSC | 1.65 |
| ccRCC | -0.051 |
| GBM | -0.095 |
| HNSC | -0.488 |
| LUAD | -1.952 |
| LUSC | -0.351 |
| non_ccRCC | 1.276 |
| PDAC | -0.344 |
| UCEC | 0.805 |
| TP53BP1-Ser1691 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser1706 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | -0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1710 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.394 |
| COAD | 0.841 |
| HGSC | -0.038 |
| ccRCC | |
| GBM | |
| HNSC | 0.59 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1763 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.438 |
| HGSC | -0.706 |
| ccRCC | |
| GBM | |
| HNSC | 1.144 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1764 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | -0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser1976 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser207 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | -1.152 |
| GBM | |
| HNSC | 0.647 |
| LUAD | 0.505 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser213 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -1.494 |
| ccRCC | |
| GBM | 0.482 |
| HNSC | |
| LUAD | |
| LUSC | 0.615 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.398 |
| TP53BP1-Ser227 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.559 |
| COAD | 1.032 |
| HGSC | -2.558 |
| ccRCC | 0.347 |
| GBM | 0.449 |
| HNSC | -0.102 |
| LUAD | -0.028 |
| LUSC | 0.4 |
| non_ccRCC | -0.468 |
| PDAC | 1.106 |
| UCEC | 0.381 |
| TP53BP1-Ser264 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 0.99 |
| ccRCC | -0.182 |
| GBM | |
| HNSC | -0.921 |
| LUAD | -0.976 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 1.09 |
| TP53BP1-Ser270 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.282 |
| COAD | -0.547 |
| HGSC | 0.337 |
| ccRCC | 0.598 |
| GBM | -1.076 |
| HNSC | -0.407 |
| LUAD | -0.065 |
| LUSC | 0.122 |
| non_ccRCC | 2.428 |
| PDAC | -0.468 |
| UCEC | 0.359 |
| TP53BP1-Ser285 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.685 |
| COAD | |
| HGSC | |
| ccRCC | -0.745 |
| GBM | 1.526 |
| HNSC | -0.932 |
| LUAD | -0.956 |
| LUSC | -0.513 |
| non_ccRCC | 0.35 |
| PDAC | -0.309 |
| UCEC | -0.105 |
| TP53BP1-Ser292 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -1.068 |
| HGSC | |
| ccRCC | 0.155 |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | 0.914 |
| UCEC | |
| TP53BP1-Ser299 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.87 |
| COAD | -0.078 |
| HGSC | -2.675 |
| ccRCC | -0.093 |
| GBM | -0.102 |
| HNSC | 0.366 |
| LUAD | 0.294 |
| LUSC | |
| non_ccRCC | 0.809 |
| PDAC | 0.331 |
| UCEC | 0.278 |
| TP53BP1-Ser306 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.988 |
| COAD | |
| HGSC | -2.119 |
| ccRCC | -0.082 |
| GBM | 0.471 |
| HNSC | 0.168 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | 0.523 |
| UCEC | 0.051 |
| TP53BP1-Ser315 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | -0.707 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser320 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -1.367 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 0.823 |
| LUSC | -0.12 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.664 |
| TP53BP1-Ser321 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.049 |
| HGSC | -1.635 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 1.072 |
| LUSC | 0.111 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.404 |
| TP53BP1-Ser328 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.516 |
| HGSC | -1.499 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 0.462 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.521 |
| TP53BP1-Ser338 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser354 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | -0.707 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser364 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.056 |
| HGSC | -1.97 |
| ccRCC | 0.135 |
| GBM | |
| HNSC | 0.748 |
| LUAD | 0.568 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.463 |
| TP53BP1-Ser365 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.194 |
| HGSC | -2.17 |
| ccRCC | 0.331 |
| GBM | 0.514 |
| HNSC | 0.459 |
| LUAD | -0.134 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.807 |
| TP53BP1-Ser371 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.363 |
| HGSC | -2.39 |
| ccRCC | 0.224 |
| GBM | 0.432 |
| HNSC | 0.282 |
| LUAD | 0.45 |
| LUSC | 0.787 |
| non_ccRCC | -1.185 |
| PDAC | 0.322 |
| UCEC | 0.716 |
| TP53BP1-Ser384 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.738 |
| HGSC | -1.53 |
| ccRCC | 0.308 |
| GBM | 0.046 |
| HNSC | 1.09 |
| LUAD | -0.451 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 1.275 |
| TP53BP1-Ser385 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.386 |
| HGSC | -0.687 |
| ccRCC | -1.022 |
| GBM | 0.177 |
| HNSC | 1.595 |
| LUAD | |
| LUSC | |
| non_ccRCC | -1.225 |
| PDAC | 0.946 |
| UCEC | 0.602 |
| TP53BP1-Ser400 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | 0.404 |
| LUAD | -1.139 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.735 |
| TP53BP1-Ser403 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.985 |
| COAD | -0.068 |
| HGSC | 1.876 |
| ccRCC | -0.131 |
| GBM | -0.285 |
| HNSC | 0.06 |
| LUAD | -1.371 |
| LUSC | -0.905 |
| non_ccRCC | 1.623 |
| PDAC | 0.257 |
| UCEC | -0.07 |
| TP53BP1-Ser498 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | -0.707 |
| GBM | |
| HNSC | |
| LUAD | 0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser505 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.037 |
| COAD | 0.014 |
| HGSC | -2.9 |
| ccRCC | 0.331 |
| GBM | 0.067 |
| HNSC | 0.367 |
| LUAD | 0.392 |
| LUSC | 0.005 |
| non_ccRCC | 0.902 |
| PDAC | 0.485 |
| UCEC | 0.375 |
| TP53BP1-Ser512 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.485 |
| COAD | 0.489 |
| HGSC | -0.63 |
| ccRCC | 0.023 |
| GBM | 0.487 |
| HNSC | 1.573 |
| LUAD | 0.259 |
| LUSC | -0.106 |
| non_ccRCC | -1.184 |
| PDAC | -0.978 |
| UCEC | -1.417 |
| TP53BP1-Ser517 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | -0.707 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser523 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -0.69 |
| ccRCC | 0.759 |
| GBM | |
| HNSC | 0.019 |
| LUAD | -1.257 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 1.17 |
| TP53BP1-Ser525 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.506 |
| HGSC | 0.654 |
| ccRCC | 0.077 |
| GBM | -2.217 |
| HNSC | 0.145 |
| LUAD | 0.301 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.535 |
| TP53BP1-Ser528 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.171 |
| HGSC | -1.639 |
| ccRCC | -0.136 |
| GBM | 0.779 |
| HNSC | -0.185 |
| LUAD | -0.644 |
| LUSC | 2.069 |
| non_ccRCC | 0.763 |
| PDAC | -0.411 |
| UCEC | -0.425 |
| TP53BP1-Ser530 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.036 |
| COAD | 0.178 |
| HGSC | -1.733 |
| ccRCC | 0.596 |
| GBM | 0.017 |
| HNSC | 0.345 |
| LUAD | -1.451 |
| LUSC | -0.164 |
| non_ccRCC | 2.072 |
| PDAC | 0.245 |
| UCEC | -0.069 |
| TP53BP1-Ser535 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 1.018 |
| ccRCC | |
| GBM | -0.981 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.037 |
| TP53BP1-Ser537 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 0.707 |
| ccRCC | |
| GBM | -0.707 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser557 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.648 |
| COAD | -0.154 |
| HGSC | -2.781 |
| ccRCC | 0.241 |
| GBM | -0.252 |
| HNSC | 0.948 |
| LUAD | -0.18 |
| LUSC | 0.094 |
| non_ccRCC | 0.681 |
| PDAC | 0.458 |
| UCEC | 0.296 |
| TP53BP1-Ser571 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.576 |
| COAD | 1.754 |
| HGSC | -0.006 |
| ccRCC | -0.236 |
| GBM | -1.184 |
| HNSC | 0.071 |
| LUAD | -0.992 |
| LUSC | -0.507 |
| non_ccRCC | 0.32 |
| PDAC | 1.875 |
| UCEC | -0.519 |
| TP53BP1-Ser585 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.535 |
| COAD | -1.562 |
| HGSC | -1.703 |
| ccRCC | 0.742 |
| GBM | -0.353 |
| HNSC | -0.287 |
| LUAD | -0.472 |
| LUSC | 0.187 |
| non_ccRCC | 1.433 |
| PDAC | 1.064 |
| UCEC | 0.415 |
| TP53BP1-Ser603 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | 1.323 |
| ccRCC | -0.58 |
| GBM | -0.26 |
| HNSC | |
| LUAD | |
| LUSC | -1.028 |
| non_ccRCC | -0.475 |
| PDAC | 1.521 |
| UCEC | -0.501 |
| TP53BP1-Ser635 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | -1.368 |
| ccRCC | -0.486 |
| GBM | 1.411 |
| HNSC | 0.686 |
| LUAD | |
| LUSC | |
| non_ccRCC | 0.327 |
| PDAC | |
| UCEC | -0.57 |
| TP53BP1-Ser640 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.305 |
| COAD | |
| HGSC | -1.283 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | 0.827 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.76 |
| TP53BP1-Ser644 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.334 |
| COAD | 0.02 |
| HGSC | -1.641 |
| ccRCC | -0.056 |
| GBM | 0.081 |
| HNSC | 0.04 |
| LUAD | 0.851 |
| LUSC | |
| non_ccRCC | |
| PDAC | 1.617 |
| UCEC | 0.421 |
| TP53BP1-Ser645 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.351 |
| COAD | 0.124 |
| HGSC | -1.73 |
| ccRCC | -0.073 |
| GBM | 0.456 |
| HNSC | 0.134 |
| LUAD | 0.53 |
| LUSC | |
| non_ccRCC | |
| PDAC | 1.6 |
| UCEC | 0.31 |
| TP53BP1-Ser664 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.928 |
| COAD | |
| HGSC | |
| ccRCC | 0.231 |
| GBM | -1.015 |
| HNSC | 0.184 |
| LUAD | 0.689 |
| LUSC | |
| non_ccRCC | 0.698 |
| PDAC | 0.045 |
| UCEC | 1.095 |
| TP53BP1-Ser665 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.928 |
| COAD | |
| HGSC | |
| ccRCC | 0.231 |
| GBM | -1.015 |
| HNSC | 0.184 |
| LUAD | 0.689 |
| LUSC | |
| non_ccRCC | 0.698 |
| PDAC | 0.045 |
| UCEC | 1.095 |
| TP53BP1-Ser667 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.933 |
| COAD | |
| HGSC | |
| ccRCC | 0.323 |
| GBM | -1.024 |
| HNSC | 0.17 |
| LUAD | 0.673 |
| LUSC | |
| non_ccRCC | 0.682 |
| PDAC | 0.032 |
| UCEC | 1.078 |
| TP53BP1-Ser679 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.707 |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser68 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.987 |
| COAD | -2.012 |
| HGSC | -1.715 |
| ccRCC | 0.437 |
| GBM | 0.453 |
| HNSC | -0.118 |
| LUAD | -0.346 |
| LUSC | 0.676 |
| non_ccRCC | 0.387 |
| PDAC | 0.38 |
| UCEC | 0.871 |
| TP53BP1-Ser697 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | -0.055 |
| LUAD | -1.182 |
| LUSC | 1.264 |
| non_ccRCC | -0.027 |
| PDAC | |
| UCEC | |
| TP53BP1-Ser718 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | 0.707 |
| GBM | |
| HNSC | -0.707 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser726 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | -0.447 |
| GBM | 1.442 |
| HNSC | 0.504 |
| LUAD | -0.336 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -1.163 |
| TP53BP1-Ser729 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.13 |
| HGSC | -2.257 |
| ccRCC | 0.179 |
| GBM | -0.219 |
| HNSC | 0.587 |
| LUAD | 0.141 |
| LUSC | 0.884 |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.814 |
| TP53BP1-Ser732 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.208 |
| COAD | 0.142 |
| HGSC | -2.711 |
| ccRCC | 0.191 |
| GBM | -0.037 |
| HNSC | 0.05 |
| LUAD | 0.206 |
| LUSC | 0.05 |
| non_ccRCC | 0.327 |
| PDAC | 1.45 |
| UCEC | 0.541 |
| TP53BP1-Ser770 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.423 |
| COAD | |
| HGSC | |
| ccRCC | -0.747 |
| GBM | |
| HNSC | |
| LUAD | -0.37 |
| LUSC | |
| non_ccRCC | -0.983 |
| PDAC | 1.775 |
| UCEC | -0.098 |
| TP53BP1-Ser776 | |
|---|---|
| Cancer | Intensity |
| BRCA | 0.271 |
| COAD | 0.765 |
| HGSC | -2.79 |
| ccRCC | 0.158 |
| GBM | -0.191 |
| HNSC | -0.218 |
| LUAD | 0.138 |
| LUSC | -0.044 |
| non_ccRCC | 0.472 |
| PDAC | 1.01 |
| UCEC | 0.428 |
| TP53BP1-Ser787 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.707 |
| TP53BP1-Ser789 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.416 |
| HGSC | -0.725 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 1.141 |
| TP53BP1-Ser791 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.396 |
| HGSC | -0.758 |
| ccRCC | -0.504 |
| GBM | -0.548 |
| HNSC | |
| LUAD | -0.418 |
| LUSC | |
| non_ccRCC | 0.571 |
| PDAC | |
| UCEC | 2.053 |
| TP53BP1-Ser814 | |
|---|---|
| Cancer | Intensity |
| BRCA | 1.193 |
| COAD | 0.263 |
| HGSC | -1.342 |
| ccRCC | 0.174 |
| GBM | 0.512 |
| HNSC | -0.612 |
| LUAD | 0.029 |
| LUSC | -1.749 |
| non_ccRCC | 1.038 |
| PDAC | 1.19 |
| UCEC | -0.696 |
| TP53BP1-Ser83 | |
|---|---|
| Cancer | Intensity |
| BRCA | -1.09 |
| COAD | |
| HGSC | 0.998 |
| ccRCC | |
| GBM | 0.683 |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.591 |
| TP53BP1-Ser835 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.165 |
| HGSC | -2.217 |
| ccRCC | 0.396 |
| GBM | 0.155 |
| HNSC | 0.71 |
| LUAD | 0.221 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.57 |
| TP53BP1-Ser836 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.736 |
| COAD | 0.068 |
| HGSC | -2.686 |
| ccRCC | 0.772 |
| GBM | 0.974 |
| HNSC | 0.564 |
| LUAD | 0.065 |
| LUSC | 0.48 |
| non_ccRCC | 0.333 |
| PDAC | -0.008 |
| UCEC | 0.173 |
| TP53BP1-Ser839 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.583 |
| COAD | -0.188 |
| HGSC | -2.68 |
| ccRCC | 1.035 |
| GBM | 0.581 |
| HNSC | 0.651 |
| LUAD | 0.173 |
| LUSC | 0.34 |
| non_ccRCC | 0.331 |
| PDAC | -0.215 |
| UCEC | 0.556 |
| TP53BP1-Ser865 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | -0.191 |
| GBM | 0.78 |
| HNSC | 0.126 |
| LUAD | -1.599 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.885 |
| TP53BP1-Ser867 | |
|---|---|
| Cancer | Intensity |
| BRCA | -0.274 |
| COAD | -0.662 |
| HGSC | -2.153 |
| ccRCC | 0.879 |
| GBM | 1.09 |
| HNSC | 0.043 |
| LUAD | -0.521 |
| LUSC | -0.128 |
| non_ccRCC | |
| PDAC | 0.631 |
| UCEC | 1.096 |
| TP53BP1-Ser872 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | 0.707 |
| HGSC | -0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Ser980 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 0.791 |
| HNSC | -1.124 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | 0.333 |
| TP53BP1-Thr1060 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | |
| HGSC | |
| ccRCC | |
| GBM | 1.029 |
| HNSC | -0.968 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | -0.062 |
| TP53BP1-Thr1061 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.269 |
| HGSC | -0.937 |
| ccRCC | |
| GBM | 1.254 |
| HNSC | -0.884 |
| LUAD | 0.836 |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Thr1127 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.707 |
| HGSC | 0.707 |
| ccRCC | |
| GBM | |
| HNSC | |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
| TP53BP1-Thr1297 | |
|---|---|
| Cancer | Intensity |
| BRCA | |
| COAD | -0.984 |
| HGSC | |
| ccRCC | |
| GBM | 1.016 |
| HNSC | -0.032 |
| LUAD | |
| LUSC | |
| non_ccRCC | |
| PDAC | |
| UCEC | |
